ADUS
Addus HomeCare Corp
NASDAQ · Healthcare · Medical - Care Facilities · US
$125.65
−0.71%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.5B | 1.4B | 1.2B | 1.1B | 951.1M |
| Cost of Revenue | 1.0B | 960.7M | 779.6M | 718.8M | 651.4M |
| Gross Profit | 485.4M | 461.9M | 375.0M | 339.9M | 299.7M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 313.9M | 306.8M | 258.8M | 231.7M | 216.9M |
| General & Admin Expense | 313.9M | 306.8M | 258.8M | 234.8M | 216.9M |
| Selling & Marketing Expense | — | — | — | (3.1M) | — |
| Other Expenses | 16.4M | 16.4M | 13.5M | 17.2M | 14.1M |
| Total Operating Expenses | 330.3M | 323.3M | 272.3M | 248.9M | 231.0M |
| Cost and Expenses | 1.3B | 1.3B | 1.1B | 967.7M | 882.4M |
| Operating Income (EBIT) | 155.1M | 138.6M | 102.7M | 91.0M | 68.7M |
| Non-Operating | |||||
| Interest Income | 1.7M | 1.6M | 4.4M | 1.5M | 341.0K |
| Interest Expense | 7.3M | 9.6M | 7.7M | 11.1M | 8.9M |
| Net Interest Income | (4.9M) | (8.0M) | (3.3M) | (9.6M) | (8.6M) |
| Other Non-Op Income/Expense | (5.6M) | (11.2M) | (3.3M) | (9.6M) | (8.6M) |
| Non-Operating Income (excl Interest) | (1.7M) | 1.6M | (4.4M) | (1.5M) | (341.0K) |
| EBT (Pre-Tax Income) | 149.5M | 127.4M | 99.4M | 81.3M | 60.2M |
| Income Tax Expense | 38.5M | 31.5M | 25.8M | 18.8M | 14.1M |
| Bottom Line | |||||
| Net Income | 111.1M | 95.9M | 73.6M | 62.5M | 46.0M |
| Earnings from Cont. Ops | 111.1M | 95.9M | 73.6M | 62.5M | 46.0M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 111.1M | 95.9M | 73.6M | 62.5M | 46.0M |
| Per Share | |||||
| Basic EPS | $6.00 | $5.19 | $4.33 | $3.91 | $2.90 |
| Diluted EPS | $6.00 | $5.21 | $4.23 | $3.83 | $2.84 |
| Revenue Per Share | $80.86 | $77.11 | $67.89 | $65.24 | $58.97 |
| Shares | |||||
| Basic Shares Outstanding | 18.6M | 18.4M | 17.0M | 16.2M | 16.1M |
| Diluted Shares Outstanding | 18.6M | 18.4M | 17.4M | 16.3M | 16.2M |
| Profitability Metrics | |||||
| EBITDA | 173.2M | 153.4M | 120.6M | 106.6M | 83.1M |
| D&A | 16.4M | 16.4M | 13.5M | 14.1M | 14.1M |
| EBIT | 117.0M | 137.0M | 107.1M | 92.4M | 69.1M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026